Structured JSON API for this factor page: https://sharemaestro.com/factors/api/tickers/eb64bade-4c9e-49a5-a30d-539ebca2200e/
AMRX
Amneal Pharmaceuticals, Inc. Class A Common StockSnapshot 2026-08-02 · 0.1w · Fresh
Strategy Eligibility
2 of 23 passing
★
OS Composite
✗
↗
Trending Value
✗
◆
Quality × Value
✗
🏛
Cornerstone Value
✗
🌿
Cornerstone Growth
✗
💎
Deep Value
✗
◇
VC2 Cheapest
✗
📐
EBITDA/EV
✗
◐
Veiled Value
✗
▣
Piotroski Bargains
✗
🔬
Quality Compounders
✗
📈
Consistent Earners
✗
🌱
GARP
✗
🔄
Shareholder Yield
✗
💰
High Yield
✗
🚀
Momentum Leaders
12-1 119%
◉
Market Leaders
✗
◎
Tiny Titans
✗
🔍
Small Cap Value
✗
🛡
Low Volatility
✗
🏷
Sector Cheapest
✗
🧠
Capital Allocators
✗
⚡
Risk-Adj Momentum
RAM 3.32
V
Value Analysis
Cheapness relative to fundamentals
16.0%ile
P/E
37.1×
P/S
1.9×
P/B
177.1×
E/P
0.0527
FCF Yield
0.037
EBITDA/EV
0.076
SH Yield
0.000
Relative Strength Across Value Dimensions
Multiples & Yields — Decomposition
VC1 (5-Factor)
89.00000000
/100 — 1=cheapest
VC2 (Trending Value)
92.00000000
/100
VC3 (Buyback)
92.00000000
/100
P/E of 37.1x is premium-priced — the market is paying up for expected growth. VC2 score of 92.00000000/100 — expensive across all six composite measures.
Q
Quality Analysis
Profitability, efficiency, balance sheet & earnings quality
82.0%ile
ROE
4.772
ROA
0.042
Net Margin
0.051
Op Margin
0.144
GPA
0.325
D/E
110.81
Current
2.20
F-Score
7/9
Quality Radar — Relative Strength
Profitability & Leverage Breakdown
Rev Growth
0.093
Stability
1.554
lower=better
Accruals
-0.011
lower=better
5yr Consist
No
ROE of 477% is exceptional. Highly leveraged with D/E of 110.81 — returns are being amplified by debt.
M
Momentum & Risk
Price trend, volatility regime, risk-adjusted returns
96.0%ile
6M Return
33.9%
12M Return
134.0%
12-1 Mom
119.0%
Risk-Adj
3.32
Vol 252d
35.9%
Vol 60d
83.7%
↑ Expanding
Max DD 12M
-20.2%
Return Comparison — 6M / 12M / 12-1
Volatility Regime — 60d vs 252d
12-1 momentum of 119% is very strong — a clear uptrend. Risk-adjusted momentum of 3.32 is excellent — strong returns relative to volatility. Near-term vol (84%) is expanding vs long-term (36%) — risk is increasing.
OS
Composite & Factor Heatmap
All factors at a glance
0.58
Pillar Balance — Value / Quality / Momentum
Factor Heatmap — green=strong, red=weak
▦
Sector Context
Healthcare
· 500 peers
Sector Value %ile
5.4%
Sector Quality %ile
85.4%
P/E z-score
0.14
P/B z-score
-0.05
Sector Avg OS
64.6%
Ticker vs Sector Averages
Relative Valuation Z-Score
Top Sector Peers (By OS)
Factor Interactions
Quality Momentum — Expensive
Strong quality (82th) and momentum (96th) but expensive (16th value). Premium priced — watch for mean reversion.
Leveraged Returns
Strong ROE (477%) boosted by high leverage (D/E 110.8). Returns look good but come with balance sheet risk.
Quality at a Premium
High quality (82th) but expensive (16th value). Upside may be limited without earnings growth.
Volatility Expanding
60-day vol (84%) significantly exceeds 252-day (36%). Near-term risk is elevated.
⚖
Factor Analysis
Comprehensive factor intelligence — strengths, weaknesses & cross-factor profile
Value
D
34.6% avg (7 factors)
Quality
C
50.9% avg (8 factors)
Momentum
A
95.0% avg (4 factors)
Risk
C
56.9% avg (1 factors)
▲ Top Strengths — highest scoring factors
▼ Key Weaknesses — lowest scoring factors
Score Trends9 snapshots
Factor Persistence9 snapshots
| Factor | Current | Streak | Trend | Spark |
|---|---|---|---|---|
| OS Composite | 0.580 | —0 | — | |
| Value %ile | 0.160 | —8 | — | |
| Quality %ile | 0.820 | —1 | — | |
| Momentum %ile | 0.960 | —9 | — | |
| F-Score | 7.000 | —9 | — | |
| Confidence | 0.939 | —9 | — | |
| Volatility | 0.359 | —0 | — |
Value Lens2021-08-03 → 2026-08-02
P/E Ratio
Earnings Yield
Value FactorsCheapness relative to fundamentals — lower multiples = cheaper
P/E Ratio
37.12
Earnings Yield (E/P)
0.0527
Price / Sales
1.88
Price / Book
177.15
Price / Cash Flow
29.14
FCF Yield
3.7%
EBITDA / EV
7.6%
Sales Yield (1/P·S)
0.3661
Shareholder Yield
Div + net buyback / mktcap
-0.0%
Quality FactorsProfitability, efficiency, and balance sheet strength
Return on Equity
477.2%
Return on Assets
4.2%
Net Margin
5.1%
Operating Margin
14.4%
Gross Profit / Assets
Novy-Marx GPA
32.5%
Debt / Equity
110.81
Current Ratio
2.20
Accruals Ratio
(NI-OCF)/Assets — lower=better
-0.011
MomentumPrice trend strength over different horizons
6M Return
33.9%
12M Return
134.0%
12-1 Momentum
Jegadeesh-Titman (skip recent month)
119.0%
Risk-Adjusted Momentum
Mom 12-1 ÷ Vol
3.32
Growth & StabilityEarnings trajectory, consistency, and capital allocation
Revenue Growth (YoY)
9.3%
Earnings Stability (CV)
Lower = more stable
1.554
5yr Consistent
EPS up every year for 5 years
No
Piotroski F-Score
7
Buyback Yield
-0.0%
O'Shaughnessy CompositesValue Composites (WWOWS 4th Ed) — 1=cheapest, 100=most expensive
VC1 (5-factor)
P/E+P/S+P/B+P/CF+EBITDA/EV
89
VC2 (6-factor)
VC1 + Shareholder Yield — used for Trending Value
92
VC3 (6-factor)
VC1 + Buyback Yield — no dividend preference
92
Capital Allocation & AlphaAlpha within factors — quality of management decisions
Veiled Value
Expensive by P/B, cheap by everything else
No
Market Leader
Above-avg mcap+revenue, non-utility
No
All Stocks Universe
Market cap > $200M
Yes
Tiny Titan
Micro-cap, low P/S, positive momentum
No
Quarterly Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity
Annual Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity